SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 208 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,053 | -91.4% | 13,421 | -81.4% | 0.00% | -100.0% |
| Q2 2023 | $93,841 | +625506.7% | 72,185 | +751.9% | 0.00% | – |
| Q1 2023 | $15 | -11.8% | 8,473 | +61.7% | 0.00% | -100.0% |
| Q4 2022 | $17 | -100.0% | 5,239 | -84.8% | 0.00% | -66.7% |
| Q3 2022 | $169,000 | +29.0% | 34,414 | +8.4% | 0.00% | 0.0% |
| Q2 2022 | $131,000 | -30.7% | 31,752 | -2.8% | 0.00% | +50.0% |
| Q1 2022 | $189,000 | -14.5% | 32,658 | +11.1% | 0.00% | -50.0% |
| Q4 2021 | $221,000 | -27.5% | 29,396 | -13.1% | 0.00% | -50.0% |
| Q3 2021 | $305,000 | +235.2% | 33,842 | +347.4% | 0.01% | +300.0% |
| Q2 2021 | $91,000 | -5.2% | 7,564 | -2.0% | 0.00% | 0.0% |
| Q1 2021 | $96,000 | +74.5% | 7,715 | +119.8% | 0.00% | 0.0% |
| Q4 2020 | $55,000 | -56.3% | 3,510 | -73.7% | 0.00% | +100.0% |
| Q3 2020 | $126,000 | -46.8% | 13,349 | -49.5% | 0.00% | -90.0% |
| Q2 2020 | $237,000 | +23600.0% | 26,419 | +13109.5% | 0.01% | – |
| Q1 2020 | $1,000 | -99.3% | 200 | -98.8% | 0.00% | -100.0% |
| Q4 2019 | $144,000 | +42.6% | 17,251 | +54.4% | 0.01% | +71.4% |
| Q3 2019 | $101,000 | +1342.9% | 11,170 | +1621.1% | 0.01% | – |
| Q2 2019 | $7,000 | +250.0% | 649 | +148.7% | 0.00% | – |
| Q1 2019 | $2,000 | -90.0% | 261 | -77.6% | 0.00% | -100.0% |
| Q3 2018 | $20,000 | +33.3% | 1,166 | +9.3% | 0.00% | 0.0% |
| Q2 2018 | $15,000 | -94.5% | 1,067 | -92.6% | 0.00% | -95.7% |
| Q1 2018 | $274,000 | +1857.1% | 14,400 | +1630.8% | 0.02% | +1050.0% |
| Q4 2017 | $14,000 | -63.2% | 832 | -67.4% | 0.00% | -33.3% |
| Q3 2017 | $38,000 | +100.0% | 2,551 | +15.7% | 0.00% | +50.0% |
| Q2 2017 | $19,000 | +850.0% | 2,205 | +451.2% | 0.00% | – |
| Q1 2016 | $2,000 | -99.3% | 400 | -99.2% | 0.00% | -100.0% |
| Q3 2015 | $270,000 | +650.0% | 47,836 | +1391.1% | 0.03% | +766.7% |
| Q2 2015 | $36,000 | -60.0% | 3,208 | -44.3% | 0.00% | -72.7% |
| Q1 2015 | $90,000 | +1700.0% | 5,757 | +1254.6% | 0.01% | +1000.0% |
| Q3 2014 | $5,000 | +150.0% | 425 | +325.0% | 0.00% | – |
| Q2 2014 | $2,000 | – | 100 | +1566.7% | 0.00% | – |
| Q4 2013 | $0 | -100.0% | 6 | -99.6% | 0.00% | -100.0% |
| Q3 2013 | $16,000 | +700.0% | 1,541 | +446.5% | 0.00% | – |
| Q2 2013 | $2,000 | – | 282 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |